Hemant Surgical Peer Comparison

BSE: 543916

₹573.60

₹-11.40 (-1.95%)

As on 30-Oct-2026IST

Market cap

₹834 Cr

Revenue (TTM)

₹107 Cr

P/E Ratio

45.8

P/B Ratio

5.8

Div. Yield

0 %

Edit

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Market cap (₹ Cr)	834	488	452	51,112	14,676
Revenue (₹ Cr)	107	19	75	6,725	1,997
Net Profit (₹ Cr)	8.04	17.29	21.73	1,128.79	307.01
Net Margin (%)	7.20	47.19	27.10	16.02	14.56
RoE (%)	12.73	-2.13	18.08	11.51	10.63
Price to Earnings	45.84	--	20.79	45.28	46.58
Price-To-Book	5.80	0.60	3.46	4.81	4.61

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Operating Revenue	106.64	24.60	63.03	5,616.50	1,669.83
Total Income	111.76	66.85	67.09	5,830.11	1,758.96
Total Expenditure	97.54	26.37	40.69	4,347.58	1,214.12
EBITDA	9.10	-1.78	22.34	1,268.92	455.71
Depreciation	1.43	0.13	1.90	377.87	83.18
EBIT	7.67	-1.91	20.44	891.05	372.53
Interest	2.33	--	0.26	42.00	14.32
Other Income	5.12	42.25	4.07	213.61	89.13
Exceptional Items	--	--	--	--	--
Profit before Tax	10.47	95.61	24.25	1,062.66	452.52
Provision for Tax	2.42	8.60	6.09	364.13	113.96
Profit after Tax	8.04	87.02	18.16	698.53	338.56

Liabilities (₹ Cr)

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Shareholder's Funds	63.17	874.22	105.57	9,150.74	2,765.66
Minority Interest	--	--	--	--	--
Non-Current Liabilities	23.72	15.96	1.00	457.27	56.40
Current Liabilities	61.26	2.14	5.96	1,564.85	457.71
Total Liabilities	148.31	892.32	112.53	11,172.85	3,279.77

Assets (₹ Cr)

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Non-Current Assets	59.35	505.88	26.81	4,389.91	1,269.89
Current Assets	88.80	386.44	85.72	6,782.94	2,009.87
Total Assets	148.31	892.32	112.53	11,172.85	3,279.77
Total Debt*	31.03	0.00	0.00	269.21	177.65
Net Current Assets	27.54	384.30	79.75	5,218.09	1,552.17
Contingent Liabilities	5.91	4.66	--	21.38	77.12

Cashflow (₹ Cr)

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Cash From Operating Activities	8.84	184.71	14.82	914.73	233.05
Cash Flow from Investing Activities	-30.28	-185.96	-1.33	1,704.74	-1,187.18
Cash from Financing Activities	17.64	--	-1.20	-433.48	950.51
Net Cash Inflow / Outflow	-3.79	-1.26	12.29	2,185.99	-3.63

Ratios

Profitability Ratios

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
ROCE (%)	13.58	11.00	25.24	11.97	20.37
ROE (%)	12.73	10.01	18.70	7.82	16.01
ROA (%)	5.43	9.82	17.51	6.41	12.99
EBIT Margin (%)	13.33	164.57	41.90	26.40	32.63
Net Margin (%)	7.20	130.16	27.06	11.98	19.25
Cash Profit Margin (%)	8.88	354.32	30.88	19.16	25.15

Growth Ratios

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Revenue Growth (%)	0.00	-24.20	11.69	-0.85	21.37
EBIT Growth (%)	--	-0.02	15.22	-1.38	30.11
Net Profit Growth (%)	0.00	144.32	12.51	-9.57	31.09
EPS Growth (%)	0.00	144.32	12.51	-9.60	24.16
Book Value Growth (%)	0.00	1.23	19.13	4.91	88.41

Valuation Ratios

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Price / Earnings	12.94	2.25	28.34	37.55	67.10
Price / Book Value	1.65	0.22	4.87	2.87	8.22
Dividend Yield (%)	0.00	0.00	0.23	1.13	0.16
EV/EBITDA	8.83	4.84	17.17	16.15	41.75
Market Cap (₹ Cr)	104.03	196.11	514.45	26,233.01	22,718.23

Solvency Ratios

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Debt to Equity	0.49	0.00	0.00	0.03	0.06
Short term debt to equity ratio	0.05	--	--	--	0.06
Current Ratio	1.45	180.59	14.38	4.33	4.39
Quick Ratio	0.75	177.90	13.03	3.26	3.77
Interest Coverage	5.50	--	95.87	26.30	32.59

Operating Efficiency Ratios

	Hemant Surgical	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure
Debtors to sales (%)	19.11	4.86	12.17	27.00	20.94
Asset Turnover	0.72	0.03	0.63	0.52	0.64
Receivable days	69.76	24.54	44.41	99.92	67.43
Inventory Days	147.65	92.65	40.11	108.54	55.13
Payable days	187.95	10.57	41.91	138.65	74.14
Cash Conversion Cycle	29.46	106.62	42.60	69.81	48.42